The Evaluation of Novel Biomarkers and the Multiple Biomarker Approach in the Prediction of Cardiovascular Disease

Danny J. Eapen, Nima Ghasemzadeh, James P. MacNamara, Arshed Quyyumi

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

Since the release of the Framingham Risk Score in 1998 Wilson et al. (Circulation 97:1837–47, 1998), the search for blood-based biomarkers to better predict cardiovascular disease (CVD) and its associated outcomes has intensified. Multiple cardiac biomarkers have been tested over the past 2 decades, and some have been discovered to be successful in predicting such events. However, these individual biomarkers have not significantly added to existing risk algorithms (ie, the Framingham Risk Score). The hypothesis that biomarkers with small amounts of individual benefit used collectively would provide better overall prediction led to the development of aggregate biomarker models. Herein, we discuss the qualities of an ideal biomarker, statistical methods used to interrogate biomarker risk prediction algorithms, the multiple biomarker approach to cardiovascular disease, and potential strategies to use in selecting the right biomarker for aggregate biomarker models.

Original languageEnglish (US)
Article number408
Pages (from-to)1-4
Number of pages4
JournalCurrent Cardiovascular Risk Reports
Volume8
Issue number11
DOIs
StatePublished - Nov 1 2014
Externally publishedYes

Keywords

  • Biomarker
  • Calibration
  • Cardiovascular disease
  • Discrimination
  • Multiple Biomarkers
  • Net reclassification index

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'The Evaluation of Novel Biomarkers and the Multiple Biomarker Approach in the Prediction of Cardiovascular Disease'. Together they form a unique fingerprint.

Cite this